Mohinder Sarna

Mohinder Sarna

Auto-generated profile, based on publicly available information

Mohinder Sarna

Wesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, The University of Western Australia, Perth , Western Australia

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2007 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
RWR. J. Webby
R. J. Webby
KCK. S. Carville
K. S. Carville
MKM. D. Kirk
M. D. Kirk
GGG. Greening
G. Greening
RRR. M. Ratcliff
R. M. Ratcliff
GHG. Hall
G. Hall
Background. Between November 2003 and January 2004, outbreaks of norovirus in 3 Australian jurisdictions involving 83 cases of illness were associate

15 December 2017 in Thorax
Verified
Journal Article
Open access
PDF file
MSMohinder Sarna
Mohinder Sarna
SLStephen B Lambert
Stephen B Lambert
TSTheo P Sloots
Theo P Sloots
DWDavid David Whiley
David David Whiley
AAAsma Alsaleh
Asma Alsaleh
Robert WareRobert Ware
Robert Ware
Introduction Viral acute respiratory infections (ARIs) cause substantial child morbidity. Sensitive molecular-based assays aid virus detection, but the clinical significance of positive tests remains uncertain as some viruses may be found in both acutely ill and healthy children. We describe disease-pathogen associations of respiratory viruses and quantify virus-specific attributable risk of ARIs in healthy children during the first 2 years of life. Methods One hundred fifty-eight term newborn babies in Brisbane, Australia, were recruited progressively into a longitudinal, community-based, birth cohort study conducted between September 2010 and October 2014. A daily tick-box diary captured predefined respiratory symptoms from birth until their second birthday. Weekly parent-collected nasal swabs were batch-tested for 17 respiratory viruses by PCR assays, allowing calculation of virus-specific attributable fractions in the exposed (AFE) to determine the proportion of virus-positive children whose ARI symptoms could be attributed to that particular virus. Results Of 8100 nasal swabs analysed, 2646 (32.7%) were virus-positive (275 virus codetections, 3.4%), with human rhinoviruses accounting for 2058/2646 (77.8%) positive swabs. Viruses were detected in 1154/1530 (75.4%) ARI episodes and in 984/4308 (22.8%) swabs from asymptomatic periods. Respiratory syncytial virus (AFE: 68% (95% CI 45% to 82%)) and human metapneumovirus (AFE: 69% (95% CI 43% to 83%)) were strongly associated with higher risk of lower respiratory symptoms. Discussion The strong association of respiratory syncytial virus and human metapneumovirus with ARIs and lower respiratory symptoms in young children managed within the community indicates successful development of vaccines against these two viruses should provide substantial health benefits.

27 September 1999 in FEBS Letters
Verified
Journal Article
Closed access
EIEvan Ingley
Evan Ingley
JWJ.H. Williams
J.H. Williams
CWC.E. Walker
C.E. Walker
STS. Tsai
S. Tsai
SCS. Colley
S. Colley
SKS.P. Klinken
S.P. Klinken

26 May 2016 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
MSMohinder Sarna
Mohinder Sarna
Robert WareRobert Ware
Robert Ware
TSTheo P. Sloots
Theo P. Sloots
MNMichael D. Nissen
Michael D. Nissen
KGKeith Grimwood
Keith Grimwood
SLStephen B. Lambert
Stephen B. Lambert

1 November 2004 in Oncogene
Verified
Journal Article
Closed access
EIEvan Ingley
Evan Ingley
DMDavid J McCarthy
David J McCarthy
JPJessica R Pore
Jessica R Pore
MSMohinda K Sarna
Mohinda K Sarna
AAAini S Adenan
Aini S Adenan
SKS Peter Klinken
S Peter Klinken

1 March 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
EIEvan Ingley
Evan Ingley
MSMohinda K. Sarna
Mohinda K. Sarna
JBJennifer G. Beaumont
Jennifer G. Beaumont
PTPeta A. Tilbrook
Peta A. Tilbrook
STSchickwann Tsai
Schickwann Tsai
SKS. Peter Klinken
S. Peter Klinken
Erythroid cells terminally differentiate in response to erythropoietin binding its cognate receptor. Previously we have shown that the tyrosine kinase Lyn associates with the erythropoietin receptor and is essential for hemoglobin synthesis in three erythroleukemic cell lines. To understand Lyn signaling events in erythroid cells, the yeast two-hybrid system was used to analyze interactions with other proteins. Here we show that the hemopoietic-specific protein HS1 interacted directly with the SH3 domain of Lyn, via its proline-rich region. A truncated HS1, bearing the Lyn-binding domain, was introduced into J2E erythroleukemic cells to determine the impact upon responsiveness to erythropoietin. Truncated HS1 had a striking effect on the phenotype of the J2E line—the cells were smaller, more basophilic than the parental proerythoblastoid cells and had fewer surface erythropoietin receptors. Moreover, basal and erythropoietin-induced proliferation and differentiation were markedly suppressed. The inability of cells containing the truncated HS1 to differentiate may be a consequence of markedly reduced levels of Lyn and GATA-1. In addition, erythropoietin stimulation of these cells resulted in rapid, endosome-mediated degradation of endogenous HS1. The truncated HS1 also suppressed the development of erythroid colonies from fetal liver cells. These data show that disrupting HS1 has profoundly influenced the ability of erythroid cells to terminally differentiate.